Compare · ANCN vs KIN
ANCN vs KIN
Side-by-side comparison of Anchiano Therapeutics Ltd. (ANCN) and Kindred Biosciences, Inc. (KIN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ANCN and KIN operate in Major Pharmaceuticals (Health Care), so they compete in similar markets.
- KIN carries a market cap of $420.5M.
- Company
- Anchiano Therapeutics Ltd.
- Kindred Biosciences, Inc.
- Price
- -
- -
- Market cap
- -
- $420.5M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Major Pharmaceuticals
- Major Pharmaceuticals
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2019
- 2013
- News (4w)
- 0
- 0
- Recent ratings
- 0
- 0
Kindred Biosciences, Inc.
Kindred Biosciences, Inc., a commercial-stage biopharmaceutical company, engages in developing therapies for pets. Its product pipeline focuses on biologics for a range of indications primarily in dogs and cats. The company offers Mirataz, a mirtazapine transdermal ointment for the management of weight loss in cats; and Zimeta, a dipyrone injection for the control of fever in horses. It also develops KIND-016, a monoclonal antibody for the treatment of atopic dermatitis in dogs; KIND-032, a monoclonal antibody targeting interleukin-4 (IL-4) receptor for the treatment of atopic dermatitis in dogs; KIND-025 a canine fusion protein targeting IL-4 and IL-13 for atopic dermatitis in dogs; KIND-030, a monoclonal antibody targeting canine parvovirus for the prophylactic indication in dogs; KIND-509, an antibody for canine inflammatory bowel disease in dogs; KIND-510a, a long-acting feline recombinant erythropoietin being developed for the management of non-regenerative anemia in cats; and KIND-511, an anti-tumor necrosis factor treatment for newborn foals. The company was incorporated in 2012 and is headquartered in Burlingame, California.
Latest ANCN
- SEC Form 8-K/A filed by Anchiano Therapeutics Ltd.
- SEC Form 4: Ltd. Gp Israel Orbimed was granted 288,170 units of American Depository Shares
- SEC Form 4: Peter Thiel bought $0 worth of American Depositary Shares (230,536 units at $0.00)
- SEC Form 3: Peter Thiel claimed ownership of 877,973 units of American Depositary Shares
- Anchiano Announces Shareholder Approval of the Merger with Chemomab and Prices $45.5M Private Financing
- SEC Form 4 filed by Stanislav Polovets
- SEC Form 3 filed by Stanislav Polovets
- SEC Form 3 filed by Andrew Fine
- SEC Form 4 filed by Harris Neil Cohen
- SEC Form 3: Harris Neil Cohen claimed ownership of 62,110 units of Ordinary Shares
Latest KIN
- TCW Special Purpose Acquisition Corp. Appoints Nanxi Liu to Board of Directors
- SEC Form SC 13G/A filed by Kindred Biosciences, Inc. (Amendment)
- SEC Form 4 filed by Park West Asset Management Llc
- SEC Form 15-12B filed by Kindred Biosciences, Inc.
- SEC Form EFFECT filed by Kindred Biosciences, Inc.
- SEC Form SC 13D/A filed by Kindred Biosciences, Inc. (Amendment)
- SEC Form 4: Chin Richard returned $15,884,757 worth of Common Stock to the company (1,717,271 units at $9.25), closing all direct ownership in the company
- SEC Form 4: Wee Wendy returned $727,170 worth of Common Stock to the company (78,613 units at $9.25), closing all direct ownership in the company
- SEC Form 4: Bevers Denise returned $1,348,974 worth of Common Stock to the company (145,835 units at $9.25), closing all direct ownership in the company
- SEC Form 4: Zhan Hangjun returned $594,830 worth of Common Stock to the company (64,306 units at $9.25), closing all direct ownership in the company